These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7493355)

  • 1. Overview of studies on experimental radioimmunotherapy.
    Knox SJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5832s-5836s. PubMed ID: 7493355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy of the Non-Hodgkin's Lymphomas.
    Knox SJ
    Semin Radiat Oncol; 1995 Oct; 5(4):331-341. PubMed ID: 10717155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for developing effective radioimmunotherapy for solid tumors.
    DeNardo GL; O'Donnell RT; Kroger LA; Richman CM; Goldstein DS; Shen S; DeNardo SJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3219s-3223s. PubMed ID: 10541367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.
    Ng B; Kramer E; Liebes L; Wasserheit C; Hochster H; Blank E; Ceriani R; Furmanski P
    Cancer Res; 2001 Apr; 61(7):2996-3001. PubMed ID: 11306478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of infection with radiolabeled antibodies.
    Dadachova E; Casadevall A
    Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):193-204. PubMed ID: 16868533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
    Sautter-Bihl ML; Bihl H
    Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical radioimmunotherapy.
    Knox SJ; Meredith RF
    Semin Radiat Oncol; 2000 Apr; 10(2):73-93. PubMed ID: 10727597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
    Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapeutic approaches for leukemia: the past, present and future.
    Pagel JM
    Cytotherapy; 2008; 10(1):13-20. PubMed ID: 18202970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted radionuclide therapy for solid tumors: an overview.
    DeNardo SJ; Denardo GL
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S89-95. PubMed ID: 16979448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
    Sun LQ; Vogel CA; Mirimanoff RO; Coucke P; Slosman DO; Mach JP; Buchegger F
    Cancer Res; 1997 Apr; 57(7):1312-9. PubMed ID: 9102219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy and colorectal cancer.
    Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
    Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.